Medication info
Wimezol 20 mg (Esomeprazole Magnesium Trihydrate)

Wimezol 20 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›22.3mg / 1 tablet
Manufacturer / importer
Seohung Co., Ltd.
Appearance
Pale pink round film-coated tablet
Packaging
28 tablets/PTP [14 tablets/PTP X 2]
Approval status
Active

MFDS item code 201901521 · Approved 2019.03.12 · Insurance code 679601030

Summary

Main use
Treatment of reflux and excess stomach acid, Helicobacter pylori infection and ulcers; treatment and prevention of gastrointestinal disorders caused by nonsteroidal anti-inflammatory drugs
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water. Do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. 6. Older adults: No dose adjustment is necessary.
Children's dosage
Adolescents 12 years and older - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for an additional 4 weeks. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. Children under 12 years: There is no experience with administration of this medicine to children under 12 years.

Ingredients

Manufacturer
Seohung Co., Ltd.

Efficacy & effects

Treatment of reflux and excess stomach acid, Helicobacter pylori infection and ulcers; treatment and prevention of gastrointestinal disorders caused by nonsteroidal anti-inflammatory drugs

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • symptoms of gastroesophageal reflux disease without esophagitis
  • Helicobacter pylori positive duodenal ulcer
  • Helicobacter pylori positive peptic ulcer
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • NSAID-related gastric ulcer
  • NSAID-related duodenal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used in the treatment of gastroesophageal reflux disease and erosive esophagitis and for long-term maintenance therapy, also helping to relieve symptoms of gastroesophageal reflux disease without esophagitis. It is effective in the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers in conjunction with antibiotic therapy for eradication of Helicobacter pylori. It is also used for the treatment of upper gastrointestinal symptoms associated with the use of non-steroidal anti-inflammatory drugs and the treatment and prevention of related gastric and duodenal ulcers. It is applicable for the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding after intravenous administration. Overall, this medication is effective in the treatment and symptom relief of various gastrointestinal diseases, contributing to the improvement of patients' health.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water. Do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies extending beyond 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous treatment to prevent rebleeding from gastric or duodenal ulcers. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. 6. Older adults: No dose adjustment is necessary.

Children's dosage

Adolescents 12 years and older - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue taking it for an additional 4 weeks. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by taking 20 mg once daily. Children under 12 years: There is no experience with administration of this medicine to children under 12 years.

Precautions

This medication should not be used in patients who have allergies or have experienced hypersensitivity to specific ingredients or benzimidazole derivatives. Additionally, caution is needed with co-administration in patients allergic to penicillin antibiotics or macrolide antibiotics. It should also be avoided in patients on certain cardiac-related medications, antiviral agents, lactating women, and those with a history of myocardial infarction. This medication contains a dye called yellow No. 4, which should be used with caution in patients who are hypersensitive to it. Various adverse reactions may occur during use, so if symptoms such as headache, dizziness, dyspepsia, rash, or muscle pain appear, immediate consultation with medical personnel is necessary. Regular checks of blood tests or magnesium levels are important during long-term use. This medication suppresses gastric acid secretion and can increase the risk of bacterial infections in the gastrointestinal tract, so medical personnel should be informed if diarrhea persists. Moreover, prolonged high-dose use may increase the risk of fractures, thus caution is needed in osteoporosis patients. It may interact with other medications, so if other medications are being taken, it is essential to inform and consult with a doctor or pharmacist. During pregnancy, safety has not been sufficiently confirmed, so caution is advised, and it is recommended not to use during breastfeeding. In case of overdose, there is no specific antidote, so immediate medical attention should be sought and should be kept out of reach of children.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbances, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized pustular eruption, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like syndrome, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal motility disorder, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, worsening depression, muscle rigidity, sensory decrease, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disturbance, tremor, visual impairment, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbances, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, fundic gland polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture, and it is best kept at room temperature between 1 to 30 degrees Celsius. By doing so, the effectiveness of the medication can be maintained for a longer time.

Appearance and packaging

Appearance

Pale pink round film-coated tablet

Package unit

28 tablets/PTP [14 tablets/PTP X 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.